Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 4Sarcoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thymus Neoplasms 1Sarcoma, Synovial 1Prostatic Neoplasms 1Multiple Myeloma 1Mesothelioma 1Meningioma 1Melanoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fatigue 1Dermatofibrosarcoma 1Cardiovascular Diseases 1Carcinoma, Squamous Cell 1Breast Neoplasms 1Bone Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 2Doxorubicin 2selinexor 1peposertib 1pazopanib 1liposomal doxorubicin 1Specimen Handling 1Quality of Life 1Proton Therapy 1Magnetic Resonance Spectroscopy 1Ifosfamide 1Histamine H2 Antagonists 1Famotidine 1Dactinomycin 1Biopsy 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Dermatofibrosarcoma × Quality of Life × Clear all
NCT07169344 2026-01-28

PROSARC-1

Oslo University Hospital

Phase 2 Recruiting
110 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡